WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 18.08.2018 at 9:00 AM CEST
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005009976) PYRIDAZINYL- PIPERAZINES AND THEIR USE AS HISTAMINE H3 RECEPTOR LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/009976 International Application No.: PCT/DK2004/000483
Publication Date: 03.02.2005 International Filing Date: 06.07.2004
IPC:
C07D 237/20 (2006.01)
Applicants: HOHLWEG, Rolf[DE/DK]; DK (UsOnly)
NOVO NORDISK A/S[DK/DK]; Novo Allé DK-DK Bagsværd, DK (AllExceptUS)
Inventors: HOHLWEG, Rolf; DK
Common
Representative:
NOVO NORDISK A/S; Corporate Patents Novo Allé DK-DK Bagsværd, DK
Priority Data:
60/492,69305.08.2003US
PA 2003 0110729.07.2003DK
Title (EN) PYRIDAZINYL- PIPERAZINES AND THEIR USE AS HISTAMINE H3 RECEPTOR LIGANDS
(FR) PYRIDAZINYL-PIPERAZINES ET LEUR UTILISATION EN TANT QUE LIGANDS DU RECEPTEUR HISTAMINIQUE H3
Abstract: front page image
(EN) The present invention relates to piperazines of formula I. The compounds show a high and selective binding affinity for the histamine H3 receptor, indicating histamine H3 receptor antagonistic, inverse agonistic or agonistic activity. As a result, the compounds are useful for the treatment of diseases or disorders related to the histamine H3 receptor.
(FR) L'invention concerne se rapporte aux pipérazines représentées par la formule I. Ces composés présentent une affinité de liaison élevée et sélective pour le récepteur histaminique H3, indiquant une activité antagoniste, agoniste inverse ou agoniste envers le récepteur histaminique H3. Ils conviennent par conséquent pour le traitement des maladies ou des troubles liés au récepteur histaminique H3. (formule I)
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)